Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06396897

The Hospital @ Home Model of Care: A Novel Healthcare Solution for the Management of Decompensated Cirrhosis

Led by Indiana University · Updated on 2025-08-19

30

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to understand the perspectives of patients with end-stage liver disease on the Hospital at Home (H@H) Program, an emerging model of home-based care that extends traditional hospital services. The study focuses on patients with decompensated cirrhosis to assess their expectations, desired outcomes, and perceived barriers to this type of care. The goal is to see if this model can safely manage care at home while improving satisfaction and reducing healthcare use in this high-risk population. The study is divided into three phases. Phase 1 takes place while the participant is hospitalized and includes questionnaires and interviews to assess patient-reported outcomes and expectations. Phase 2 involves the clinical H@H program itself, where acute care and ancillary services like therapy and diagnostic testing are provided at home using remote monitoring devices and virtual visits by healthcare professionals. Phase 3 is a rehabilitation phase with virtual discussions and questionnaires to evaluate the participants' experiences and quality of life after the program. Participants will be involved in questionnaires, interviews, and virtual sessions to share their feedback and outcomes. Their care includes remote monitoring through Bluetooth-enabled tablets that transmit vital signs and allow communication with nurses and doctors. Researchers will measure enrollment numbers, follow-up visits, emergency visits, rehospitalizations, and mortality rates over time. The study will monitor participants for up to 90 days after the program to assess safety and effectiveness of this home-based care model.

CONDITIONS

Brief Title

Hospital @ Home Model of Care for Cirrhosis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Enrolled into IUH's Hospital at Home program
  • At least 18 years of age
  • Diagnosis of chronic liver disease or cirrhosis based on clinical, laboratory, and imaging findings
  • English speaking
  • Able to provide consent
  • Caregiver available during the first 48 hours after hospital discharge
  • Able to perform activities of daily living independently
  • Lives within IU Health Home service area
Not Eligible

You will not qualify if you...

  • Unable to complete study questionnaires due to neurocognitive disease, legal blindness, or hearing loss
  • History of transplant of an organ other than the liver
  • Pregnant
  • Incarcerated
  • New hemodialysis treatment
  • Blood pressure below 90/60, pulse over 120, or oxygen needs greater than 6L or more than 2L above baseline
  • HIV positive with CD4 count below 200
  • Receiving hospice services
  • Currently enrolled in a related research study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 screening and enrollment visit (in-person)

Hospital at Home Care

Duration - Varies depending on individual clinical needs

Participants receive hospital-level care at home through the Indiana University Health Hospital at Home Program, which includes remote monitoring, in-person and virtual visits with healthcare providers, and administration of treatments as needed.

In-person and virtual visits throughout the care period

Follow-up and Evaluation

Duration - Up to 2 years

Participants complete questionnaires and interviews to assess their experience, quality of life, and outcomes after completing the Hospital at Home program.

Multiple virtual follow-up visits including interviews and questionnaires

Trial Site Locations

Total: 1 location

1

IU School of Medicine

Indianapolis, Indiana, United States, 46202

Actively Recruiting

Loading map...

Research Team

R

Regia Weber

A

Archita Desai, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

1

Similar Trials

Branch Chain Amino Acids vs Rifaximin for Secondary Preventi...

Hepatic Encephalopathy

Actively Recruiting

1 location

Carvedilol and Simvastatin for Chronic Liver Disease and Cir...

Decompensated Cirrhosis

Actively Recruiting

1 location

CirrhoCare, A Real-world, Randomised Controlled Study to Det...

Decompensated Cirrhosis

Actively Recruiting

15 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here